CClinicalTrials.gg
CompletedNCT05569850Updated Apr 29, 2025Results posted

Efficacy of an Antibacterial Toothpaste and Patients' Satisfaction

An interventional study of Brushing in Caries and Gingivitis, sponsored by University of Bologna. Completed at 1 site in Italy. Open to participants aged 18 Years to 50 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2025-04-29.

Sponsored by University of Bologna · Not applicable, Interventional, and Prevention

Phase
Not applicable
Study type
Interventional
Enrollment
100
Allocation
Randomized
Ages
18 Years to 50 Years
Sex
All
01

Study summary

The primary objective of this randomized controlled clinical trial (RCCT) will be to compare the efficacy in reducing the quantity of Streptococcus mutans (S. Mutans) in saliva of a recently introduced toothpaste compared to a commercially available toothpaste. The secondary outcomes will be to assess patients' impression of the toothpastes (in terms of taste, satisfaction etc.), and to investigate potential changes in dentin hypersensitivity, plaque formation and gingival inflammation.

02

Conditions studied

  • Caries
  • Gingivitis

Browse trials for

03

In context

Gingivitis

590 studies on the registry are indexed under Gingivitis; 104 are open to participants now.

This study's enrollment of 100 is above the median of 64 across 478 interventional studies indexed under Gingivitis.

Browse Gingivitis studies →

Lead sponsor

University of Bologna is the lead sponsor of 153 studies on the registry; 24 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 50 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Inclusion criteria

  1. Patients with minimum 20 teeth;
  2. Good oral hygiene level (gingival bleeding index not exceeding 20%)
  3. Patients willing to participate in the study and able to sign an informed consent

Exclusion criteria

Exclusion Criteria:

  1. Tooth anomalies (amelogenesis imperfecta, dentinogenesis imperfecta etc.);
  2. Intrinsic stain (fluorosis);
  3. Caries lesions;
  4. Advanced periodontal disease (probing >2, spontaneous gum bleeding, tooth mobility >1);
  5. Smokers;
  6. Use of orthodontic devices;
  7. Use of antibiotics in the last 3 months;
  8. Use of antibacterial mouth rinses in the last 3 months;
  9. Potential allergies;
  10. Drug and alcohol abuse;
05

Study design

Phase
Not applicable
Primary purpose
Prevention
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Double (Participant, Outcomes assessor)
Enrollment
100 participants (actual)

Study arms

  • Experimental
    Recently introduced toothpaste

    Brushing twice a day with a recently introduced toothpaste.

    Other: Brushing

  • Active comparator
    Commercial toothpaste

    Brushing twice a day with a commercially available toothpaste.

    Other: Brushing

Interventions

  • OtherBrushing

    Brushing the teeth 2x a day for 4 weeks.

06

What researchers measure

Primary outcomes

  1. Bacterial Count of Streptococcus Mutans (S. Mutans)

    Agar Mitis salivarius with tellurium and bacitracin (MSTB) will be used for S. mutans isolation. The 0.1 ml saliva sample will be diluted with 0.9 ml of sterile normal saline; next, decimal dilutions of saliva will be made up to 10-3. Each medium plate will be cultured from 0.1 ml of the previously diluted sample to 10-3; then, the sample will be uniformly spread on the agar plates. Finally, the plates will be sealed. They will be incubated for 48 hours at 37°C. The bacterial colonies will be observed under a stereo microscope and identified by morphology and color. The CFU will be multiplied by the number of times the sample was originally diluted and expressed as the number of colony forming units per millilitre (CFU/mL) of saliva.

    Time frame: 4 weeks

Secondary outcomes

  1. Plaque Index

    The plaque will be disclosed using a disclosing solution and recorded as follows: score 0 = absence of plaque; score 1 = separate flecks of plaque on the cervical margin; score 2 = a thin, continuous band of plaque \[up to 1 mm\] at the cervical margin of the tooth; score 3 = a band of plaque wider than 1 mm, but covering less than one-third of the tooth crown; score 4 = plaque covering at least one-third, but less than two-third of the crown of the tooth; score 5 = plaque covering 2/3-crown or more of the crown of the tooth.

    Time frame: 4 weeks

  2. Gingival Index

    A North Carolina periodontal probe (Hu-Friedy, Chicago, IL, USA) will be used for determine gingival index according to the following scale: score 0 = absence of inflammation; score 1 = mild inflammation-slightly slight change in color and little change in texture; score 2 = moderate inflammation-moderate glazing, redness, edema, and hypertrophy; score 3 = severe inflammation-marked redness and hypertrophy.

    Time frame: 4 weeks

  3. Dentin Hypersensitivity

    Patients with self-reported dentin hypersensitivity will be considered. A 1-s air blast from approximately 1 cm distance will be applied onto exposed dentine. The participant's response will be assessed using the 4-point Schiff Sensitivity Scale (from 0: participant does not respond, to 3: participant responds to stimulus, considers it painful, and requests discontinuation;

    Time frame: 4 weeks

  4. Tooth Colour

    Participants' satisfaction before and after treatment will be recorded and the difference will be assessed. In order to obtain the data concerning patients' satisfaction with tooth color, a questionnaire containing aesthetic numeric visual-analogue scale ranging from 1 to 10 will be given to the subjects. 1 = "Not satisfied at all" and 10 = "Very satisfied"

    Time frame: 4 weeks

07

Results

Posted Apr 29, 2025

Participant flow

Participant flow — Overall Study
MilestoneRecently Introduced ToothpasteCommercial Toothpaste
Started5050
Completed4639
Not completed411

Outcome measures

PrimaryBacterial Count of Streptococcus Mutans (S. Mutans)

Agar Mitis salivarius with tellurium and bacitracin (MSTB) will be used for S. mutans isolation. The 0.1 ml saliva sample will be diluted with 0.9 ml of sterile normal saline; next, decimal dilutions of saliva will be made up to 10-3. Each medium plate will be cultured from 0.1 ml of the previously diluted sample to 10-3; then, the sample will be uniformly spread on the agar plates. Finally, the plates will be sealed. They will be incubated for 48 hours at 37°C. The bacterial colonies will be observed under a stereo microscope and identified by morphology and color. The CFU will be multiplied by the number of times the sample was originally diluted and expressed as the number of colony forming units per millilitre (CFU/mL) of saliva.

Time frame:
4 weeks
Reported as:
Mean · log CFU/ml
Bacterial Count of Streptococcus Mutans (S. Mutans)
log CFU/mlRecently Introduced ToothpasteCommercial Toothpaste
Bacterial Count of Streptococcus Mutans (S. Mutans)4.261 ± 0.08674.277 ± 0.0931
SecondaryPlaque Index

The plaque will be disclosed using a disclosing solution and recorded as follows: score 0 = absence of plaque; score 1 = separate flecks of plaque on the cervical margin; score 2 = a thin, continuous band of plaque \[up to 1 mm\] at the cervical margin of the tooth; score 3 = a band of plaque wider than 1 mm, but covering less than one-third of the tooth crown; score 4 = plaque covering at least one-third, but less than two-third of the crown of the tooth; score 5 = plaque covering 2/3-crown or more of the crown of the tooth.

Time frame:
4 weeks
Reported as:
Mean · score on a scale
Plaque Index
score on a scaleRecently Introduced ToothpasteCommercial Toothpaste
Plaque Index0.1 ± 0.050.17 ± 0.1
SecondaryGingival Index

A North Carolina periodontal probe (Hu-Friedy, Chicago, IL, USA) will be used for determine gingival index according to the following scale: score 0 = absence of inflammation; score 1 = mild inflammation-slightly slight change in color and little change in texture; score 2 = moderate inflammation-moderate glazing, redness, edema, and hypertrophy; score 3 = severe inflammation-marked redness and hypertrophy.

Time frame:
4 weeks
Reported as:
Mean · score on a scale
Gingival Index
score on a scaleRecently Introduced ToothpasteCommercial Toothpaste
Gingival Index0 ± 00 ± 0
SecondaryDentin Hypersensitivity

Patients with self-reported dentin hypersensitivity will be considered. A 1-s air blast from approximately 1 cm distance will be applied onto exposed dentine. The participant's response will be assessed using the 4-point Schiff Sensitivity Scale (from 0: participant does not respond, to 3: participant responds to stimulus, considers it painful, and requests discontinuation;

Time frame:
4 weeks
Reported as:
Mean · units on a scale
Dentin Hypersensitivity
units on a scaleRecently Introduced ToothpasteCommercial Toothpaste
Dentin Hypersensitivity0.19 ± 0.10.2 ± 0.1
SecondaryTooth Colour

Participants' satisfaction before and after treatment will be recorded and the difference will be assessed. In order to obtain the data concerning patients' satisfaction with tooth color, a questionnaire containing aesthetic numeric visual-analogue scale ranging from 1 to 10 will be given to the subjects. 1 = "Not satisfied at all" and 10 = "Very satisfied"

Time frame:
4 weeks
Reported as:
Median · units on a scale
Tooth Colour
units on a scaleRecently Introduced ToothpasteCommercial Toothpaste
Tooth Colour8 ± 0.57.8 ± 0.5

Adverse events

Collected over Up to 4 weeks.. Non-serious events are listed at a 0% frequency threshold.

Adverse event summary by group
GroupDeathsSeriousOther
Recently Introduced Toothpaste0/50 (0%)0/50 (0%)0/50 (0%)
Commercial Toothpaste0/50 (0%)0/50 (0%)0/50 (0%)

Baseline characteristics

Age, Categorical
Age, Categorical(Participants)Recently Introduced ToothpasteCommercial ToothpasteTotal
<=18 years000
Between 18 and 65 years5050100
>=65 years000
Age, Continuous
Age, Continuous(years)Recently Introduced ToothpasteCommercial ToothpasteTotal
Mean25.7 ± 0.325.3 ± 0.425.5 ± 0.35
Sex: Female, Male
Sex: Female, Male(Participants)Recently Introduced ToothpasteCommercial ToothpasteTotal
Female292655
Male212445
Race and Ethnicity Not Collected
Race and Ethnicity Not Collected(Participants)Recently Introduced ToothpasteCommercial ToothpasteTotal
Count of participants——0
Region of Enrollment
Region of Enrollment(participants)Recently Introduced ToothpasteCommercial ToothpasteTotal
Italy463985
08

Study locations

1 site
  • DIBINEM
    Bologna, BO 40125, Italy
09

References and documents

Study documents

  • Protocol and statistical analysis plan · Nov 20, 2024
  • Informed consent form · Nov 20, 2024

Documents are hosted by the registry — open the source record to download them.

Individual participant data

Plan to share: Undecided

10

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Apr 29, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
11

Registry details

Key details

Study ID
NCT05569850
Lead sponsor
University of Bologna
Collaborators
Unilever R&D
Responsible party
Lorenzo Breschi (Professor, University of Bologna) — Principal investigator
First posted
Oct 6, 2022
Start date
Dec 1, 2022
Primary completion
Jul 15, 2023
Completion
Jul 15, 2023
Results posted
Apr 29, 2025
Last update
Apr 29, 2025

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Apr 2025. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion